Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT05996159
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Registry
-
NCT05996159
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT05996159. Randomized; no masking; primary purpose treatment. Start 2023-11-07 (actual); primary completion 2026-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- QDOT MicroTM catheter
- Intervention (Device)
- AI-guided ablation only for PVI
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct05996159- Content hash
17bc7e051b4b77e0cca0ff9d216e6fc390810f1a5c95947ce58998d00a11f062